Women can use their growing wealth and influence to build the world they desire through investing in new innovations and companies, believes Trish Costello, founder and CEO of fintech company Portfolia.
What You Should Know:
– Bone Health Technologies, a San Francisco-based provider of technologies for improving bone health, announces today the close of its $2.5 million funding round and the appointment of three board members: Karen Drexler, MBA, Nancy Lynch, MD, MBA and Sam Goldberger, MD, MBA.
– 1 in 2 women and 1 in 4 men over 50 will suffer an osteoporosis related fracture. To address this rising issue, the company has created OsteoBoost, the first vibration belt specifically designed for the prevention of osteoporosis. The OsteoBoost Vibration Belt applies gentle mechanical stimulation to the hips and spine to reduce bone loss and encourage bone growth.
– Currently being studied in a National Institutes of Health (NIH) funded clinical trial, based on a successful pilot study that showed one 30-minute treatment with OsteoBoost reduced bone loss activity in all study participants.
email article
Adults with type 2 diabetes and cardiovascular disease who took empagliflozin (Jardiance) had lower total annual healthcare costs versus those who took other name brand diabetes medication, according to a retrospective analysis from Highmark and Boehringer Ingelheim.
The FDA warned against purchasing a slew of over-the-counter weight loss products, largely sold on Amazon and eBay, that contain dangerous unlabeled ingredients.
A joint task force from the National Kidney Foundation and American Society of Nephrology on reassessing inclusion of race in the diagnosis of kidney diseases is calling for commentary in January to help draft their final report.
In an analysis of nutrition and diet peer-reviewed studies published in the 10 most-cited journals in 2018, 13.4% of papers listed disclosures involving the food industry; the publication with the highest proportion was the
Bone Health Technologies introduces the OsteoBoost Vibration Belt, designed to help treat osteopenia and prevent osteoarthritis. It has been granted “Breakthrough Device” designation by the US Food & Drug Administration.
OsteoBoost uses proprietary vibration technology designed to deliver gentle mechanical stimulation to the hips and spine at a precise, individually calibrated frequency, encouraging the body to reduce bone resorption and potentially create new bone. This localized vibration therapy’s effect is to stop the progression of bone loss and prevent the onset of osteoporosis.
An initial study suggests that one 30-minute treatment with OsteoBoost helps reduce bone loss activity in all study participants, providing an average decrease of 14%, a reduction on par with bisphosphonate drugs.